Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Recruiting
Clinical Trial of Mexiletine Hydrochloride for Spinal and Bulbar Muscular Atrophy
NCT06862596· Phase 2/3· Masahisa Katsuno· Source
Contact: Tomotaka Yamamoto, PhD, MD
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error